The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 31, 2024

Filed:

May. 13, 2021
Applicant:

Plasma Technologies, Llc, Charleston, SC (US);

Inventors:

Eugene Zurlo, Charleston, SC (US);

David Peter Nowotnik, Colleyville, TX (US);

Charles Heldebrant, Arcadia, CA (US);

Dennis Curtin, New York, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 1/36 (2006.01); A61K 35/14 (2015.01); A61K 38/36 (2006.01); A61K 38/37 (2006.01); A61K 38/38 (2006.01); A61K 38/48 (2006.01); A61K 38/57 (2006.01); B01D 15/36 (2006.01); B01D 15/38 (2006.01); B01D 61/02 (2006.01); B01D 61/14 (2006.01); C07K 1/16 (2006.01); C07K 1/22 (2006.01); C07K 1/30 (2006.01); C07K 1/34 (2006.01); C07K 14/81 (2006.01); C07K 16/06 (2006.01);
U.S. Cl.
CPC ...
C07K 1/36 (2013.01); A61K 35/14 (2013.01); A61K 38/36 (2013.01); A61K 38/363 (2013.01); A61K 38/37 (2013.01); A61K 38/38 (2013.01); A61K 38/4846 (2013.01); A61K 38/57 (2013.01); B01D 15/361 (2013.01); B01D 15/3814 (2013.01); B01D 61/027 (2013.01); B01D 61/145 (2013.01); C07K 1/16 (2013.01); C07K 1/22 (2013.01); C07K 1/30 (2013.01); C07K 1/34 (2013.01); C07K 14/81 (2013.01); C07K 16/06 (2013.01); B01D 2315/16 (2013.01);
Abstract

Methods of producing multiple protein products from blood-based materials including alpha-1-proteinase inhibitor, gamma globulin, albumin, and other proteins are described herein. The inventive methods include steps of: salt fractionation, chromatography, ultrafiltration, diafiltration, solvent-detergent treatment, and sterile filtration. Advantageously, the inventive methods are simple and produce alpha-1-proteinase inhibitor, gamma globulin, albumin, and other proteins in high yields. The sequence of process steps can be selected to obtain multiple products from various in-process materials, such as supernatants, pastes, chromatography flow-though, and chromatography washes.


Find Patent Forward Citations

Loading…